U.S. Oncology Drugs Market Size, Share, Analysis, By Drugs Class (Cytotoxic Drugs {Alkylating Agents, Antimetabolites, and Others}, Targeted Drugs {Monoclonal Antibodies, and Others}, Hormonal Drugs, and Others), By Therapy (Chemotherapy, Targeted Therapy, and Immunotherapy), By Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, and Others), By Dosage Form (Solid {Tablets and Capsules}, Liquid, and Injectable), By Distribution Channel (Hospital Pharmacies, and Retail and Online Pharmacies), and Country Forecast, 2024-2032

Last Updated: January 20, 2025 | Format: PDF | Report ID: FBI108499

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2032
Base Year	2023
Estimated Year	2024
Forecast Period	2024-2032
Historical Period	2019-2022
Growth Rate	CAGR of 9.9% from 2024 to 2032
Unit	Value (USD Billion)
Segmentation	By Drug Class Cytotoxic Drugs Alkylating Agents Antimetabolites Others Targeted Drugs Monoclonal Antibodies Others Hormonal Drugs Others
	By Therapy Chemotherapy Targeted Therapy Immunotherapy
	By Indication Lung Cancer Stomach Cancer Colorectal Cancer Breast Cancer Prostate Cancer Others
	By Dosage Form Solid Tablets Capsules Liquid Injectable Prefilled Syringes Others
	By Distribution Channel Hospital Pharmacies Retail and Online Pharmacies